While child deaths in England fell temporarily during the COVID-19 pandemic, they have now risen to new heights, a new study from researchers at the University of Bristol and based on unique National Child Mortality Database (NCMD) data has found.

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

Investigators from Mass General Brigham have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood and other fluids from patients with acute COVID-19 infections, creating the potential for guiding future treatment of patients. The research is published in Science Advances.

Engineering and medical researchers at Penn have developed a groundbreaking framework that can determine the best and most computationally optimized distribution strategy for COVID-19 vaccinations in any given community. Published in PLOS One, this study addresses one of the most critical challenges in pandemic response — how to prioritize vaccination efforts in communities with individuals of different risk levels when supplies are scarce and the stakes are high.

A nationwide RECOVER study led by The University of Texas Health Science Center at San Antonio, funded by the National Institutes of Health, finds that females are at 31% more risk for long COVID.

About The Study: This study found that female sex was associated with an increased risk of long COVID compared with male sex, and this association was age, pregnancy, and menopausal status dependent. These findings highlight the need to identify biological mechanisms contributing to sex specificity to facilitate risk stratification, targeted drug development, and improved management of long COVID.